Bio
John "Jack" Silberstein aims to use his research and expertise to bridge the gap between basic science and drug development for autoimmunity and infectious disease. His unwavering focus is on using protein engineering, immunotherapy, and precision medicine to help solve the next wave of our global healthcare system?s most burdensome diseases.
Honors & Awards
-
Bio-X Stanford Interdisciplinary Graduate Fellowship, Stanford University (2020)
-
Cancer Research Fund Award, Emerson Collective (2019)
-
Best Poster Award, Stanford Bio-X Interdisciplinary Initiatives Seed Grants Program Symposium (2019)
-
Featured on Cover, Targeted Therapies in Oncology (2017)
Professional Affiliations and Activities
-
President, Stanford Biotechnology Group (2020 - Present)
-
Partner, Mythos Biotechnology Fund (2018 - Present)
-
Board Member, Stanford Medicine Alumni Association (2018 - 2020)
Membership Organizations
-
The American Association of Immunologists, Member
-
Society for Immunotherapy of Cancer, Member
-
The Antibody Society, Member
-
American Association for the Advancement of Science, Member
Education & Certifications
-
Bachelor of Science, Wake Forest University (2014)
-
Master of Science, Johns Hopkins University (2015)